Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atorvastatin for symptomatic knee osteoarthritis
ACTRN12613000190707Phase 3Completed
- Sponsor
- Yuanyuan Wang
- Start
- Aug 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of atorvastatin in knee osteoarthritis (OA), sponsored by Yuanyuan Wang. Primary endpoint: Annual change in tibial cartilage volume. Started Aug 2013; status: completed.
02
Drugs
atorvastatin
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on ACTRN12613000190707.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12613000190707.